Skip to main contentSkip to navigation
Sirius Investors
Longduoduo Company Limited

Longduoduo Company Limited

LDDD
OTCHealthcare

Longduoduo Company Limited (LDDD) Investment Research Dashboard

About Longduoduo Company Limited (LDDD) stock analysis

Get live LDDD stock price $0.51, comprehensive Longduoduo Company Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time LDDD stock data and investment insights.

0.51
0.00%Today
Market Cap
15.31M
Volume
374
52W High
4.99
52W Low
0.51

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services. The company's comprehensive suite of offerings includ...

Company Information

CEO
Hongxiao Zhou
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
52

Contact Information

Address
G3-5-8016 Shui’an Town
Country
CN

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Longduoduo Company Limited shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Longduoduo Company Limited
  • Investors should consider how Longduoduo Company Limited fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

15.31M

P/E Ratio (TTM)

-51.00

Beta

1.16

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

66/100 ⭐⭐⭐⭐

Overall
-0.8%
NYSE
-0.8%
NASDAQ
-0.9%
Sector1D1W1MP/EScore
Communication Services+0.4%+3.4%+2.7%22.3
90/100⭐⭐⭐⭐⭐
Financial Services-0.4%+1.7%+1.8%19.0
83/100⭐⭐⭐⭐⭐
Consumer Defensive+0.5%+2.8%+3.1%29.9
82/100⭐⭐⭐⭐⭐
Healthcare-0.8%-0.9%+1.6%23.9
66/100⭐⭐⭐⭐
Energy-0.4%-3.5%-3.1%19.4
59/100⭐⭐⭐⭐
Basic Materials-1.1%-1.6%-3.7%24.9
51/100⭐⭐⭐
Real Estate-1.6%-3.3%-3.9%28.7
39/100⭐⭐
Consumer Cyclical-0.3%+0.0%-7.4%41.9
38/100⭐⭐
Utilities-2.7%-8.5%-8.2%25.9
20/100
Industrials-2.6%-5.5%-14.4%29.0
12/100
Technology-2.5%-7.7%-12.7%39.8
11/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-30.